HCA logo

HCA Healthcare (HCA) EBITDA

annual EBITDA:

$13.90B+$1.18B(+9.24%)
December 31, 2024

Summary

  • As of today (May 21, 2025), HCA annual EBITDA is $13.90 billion, with the most recent change of +$1.18 billion (+9.24%) on December 31, 2024.
  • During the last 3 years, HCA annual EBITDA has fallen by -$356.00 million (-2.50%).
  • HCA annual EBITDA is now -25.61% below its all-time high of $18.68 billion, reached on December 31, 1998.

Performance

HCA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHCAincome statement metrics

quarterly EBITDA:

$3.73B+$217.00M(+6.17%)
March 31, 2025

Summary

  • As of today (May 21, 2025), HCA quarterly EBITDA is $3.73 billion, with the most recent change of +$217.00 million (+6.17%) on March 31, 2025.
  • Over the past year, HCA quarterly EBITDA has increased by +$180.00 million (+5.06%).
  • HCA quarterly EBITDA is now -78.08% below its all-time high of $17.04 billion, reached on December 31, 1999.

Performance

HCA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHCAincome statement metrics

TTM EBITDA:

$14.08B+$180.00M(+1.30%)
March 31, 2025

Summary

  • As of today (May 21, 2025), HCA TTM EBITDA is $14.08 billion, with the most recent change of +$180.00 million (+1.30%) on March 31, 2025.
  • Over the past year, HCA TTM EBITDA has increased by +$958.00 million (+7.30%).
  • HCA TTM EBITDA is now -26.94% below its all-time high of $19.27 billion, reached on March 31, 2000.

Performance

HCA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHCAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

HCA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.2%+5.1%+7.3%
3 y3 years-2.5%+26.4%-0.5%
5 y5 years+43.8%+95.3%+55.8%

HCA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.5%+9.2%-17.1%+29.6%-0.5%+12.6%
5 y5-year-2.5%+43.8%-17.1%+95.3%-1.2%+55.8%
alltimeall time-25.6%>+9999.0%-78.1%>+9999.0%-26.9%>+9999.0%

HCA EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.73B(+6.2%)
$14.08B(+1.3%)
Dec 2024
$13.90B(+9.2%)
$3.52B(+7.8%)
$13.90B(-0.8%)
Sep 2024
-
$3.26B(-8.4%)
$14.00B(+2.8%)
Jun 2024
-
$3.56B(+0.2%)
$13.62B(+3.8%)
Mar 2024
-
$3.55B(-2.0%)
$13.12B(+3.1%)
Dec 2023
$12.72B(-4.3%)
$3.63B(+25.8%)
$12.72B(-6.5%)
Sep 2023
-
$2.88B(-5.7%)
$13.60B(-0.1%)
Jun 2023
-
$3.06B(-3.2%)
$13.62B(+0.9%)
Mar 2023
-
$3.16B(-29.9%)
$13.49B(+1.5%)
Dec 2022
$13.29B(-6.7%)
$4.50B(+55.4%)
$13.29B(+6.3%)
Sep 2022
-
$2.90B(-1.1%)
$12.50B(-9.9%)
Jun 2022
-
$2.93B(-0.7%)
$13.87B(-2.0%)
Mar 2022
-
$2.95B(-20.4%)
$14.15B(-0.7%)
Dec 2021
$14.25B(+46.4%)
$3.71B(-13.1%)
$14.25B(+4.4%)
Sep 2021
-
$4.27B(+32.8%)
$13.66B(+19.2%)
Jun 2021
-
$3.21B(+5.3%)
$11.45B(+5.3%)
Mar 2021
-
$3.05B(-2.0%)
$10.88B(+11.7%)
Dec 2020
$9.73B(+0.7%)
$3.12B(+50.8%)
$9.73B(+4.0%)
Sep 2020
-
$2.07B(-21.7%)
$9.36B(-0.1%)
Jun 2020
-
$2.64B(+38.0%)
$9.36B(+3.6%)
Mar 2020
-
$1.91B(-30.2%)
$9.04B(-6.5%)
Dec 2019
$9.66B(+3.2%)
$2.74B(+32.1%)
$9.66B(+2.4%)
Sep 2019
-
$2.07B(-10.3%)
$9.44B(-0.2%)
Jun 2019
-
$2.31B(-9.0%)
$9.46B(+0.8%)
Mar 2019
-
$2.54B(+1.0%)
$9.38B(+0.2%)
Dec 2018
$9.37B(+14.2%)
$2.52B(+20.2%)
$9.37B(+1.7%)
Sep 2018
-
$2.09B(-6.4%)
$9.21B(+3.9%)
Jun 2018
-
$2.24B(-11.4%)
$8.86B(+1.7%)
Mar 2018
-
$2.52B(+6.9%)
$8.72B(+6.3%)
Dec 2017
$8.20B(-3.3%)
$2.36B(+35.3%)
$8.20B(-1.7%)
Sep 2017
-
$1.74B(-16.6%)
$8.34B(-2.4%)
Jun 2017
-
$2.09B(+4.3%)
$8.54B(+0.5%)
Mar 2017
-
$2.01B(-19.8%)
$8.50B(+0.2%)
Dec 2016
$8.48B(+12.7%)
$2.50B(+28.5%)
$8.48B(+7.0%)
Sep 2016
-
$1.95B(-5.0%)
$7.92B(+2.7%)
Jun 2016
-
$2.05B(+2.9%)
$7.72B(+2.3%)
Mar 2016
-
$1.99B(+2.5%)
$7.55B(+0.3%)
Dec 2015
$7.53B(+6.8%)
$1.94B(+11.9%)
$7.53B(+1.2%)
Sep 2015
-
$1.74B(-7.6%)
$7.44B(-1.1%)
Jun 2015
-
$1.88B(-4.7%)
$7.52B(+1.3%)
Mar 2015
-
$1.97B(+6.1%)
$7.43B(+5.4%)
Dec 2014
$7.04B(+7.6%)
$1.86B(+2.2%)
$7.04B(+2.0%)
Sep 2014
-
$1.82B(+1.7%)
$6.91B(+3.2%)
Jun 2014
-
$1.78B(+12.5%)
$6.69B(+1.4%)
Mar 2014
-
$1.59B(-7.6%)
$6.60B(+0.8%)
Dec 2013
$6.55B(+2.8%)
$1.72B(+7.2%)
$6.55B(+4.4%)
Sep 2013
-
$1.60B(-5.4%)
$6.27B(+1.0%)
Jun 2013
-
$1.69B(+10.3%)
$6.21B(+2.1%)
Mar 2013
-
$1.53B(+6.4%)
$6.08B(-4.5%)
Dec 2012
$6.37B(-9.8%)
$1.44B(-6.4%)
$6.37B(-22.6%)
Sep 2012
-
$1.54B(-1.7%)
$8.23B(+7.0%)
Jun 2012
-
$1.57B(-14.0%)
$7.70B(+3.0%)
Mar 2012
-
$1.82B(-44.9%)
$7.48B(+5.9%)
Dec 2011
$7.06B(+22.9%)
$3.31B(+229.3%)
$7.06B(+35.7%)
Sep 2011
-
$1.00B(-25.4%)
$5.21B(-6.1%)
Jun 2011
-
$1.34B(-4.5%)
$5.55B(-1.0%)
Mar 2011
-
$1.41B(-2.8%)
$5.60B(-2.6%)
Dec 2010
$5.75B(+6.2%)
$1.45B(+7.7%)
$5.75B(+2.5%)
Sep 2010
-
$1.34B(-3.9%)
$5.61B(+1.4%)
Jun 2010
-
$1.40B(-10.1%)
$5.53B(+0.1%)
Mar 2010
-
$1.56B(+18.9%)
$5.53B(+2.1%)
Dec 2009
$5.41B(+17.5%)
$1.31B(+3.1%)
$5.41B(+1.4%)
Sep 2009
-
$1.27B(-8.8%)
$5.34B(+4.1%)
Jun 2009
-
$1.39B(-3.5%)
$5.13B(+6.4%)
Mar 2009
-
$1.44B(+17.0%)
$4.82B(+4.6%)
Dec 2008
$4.61B(-4.6%)
$1.23B(+16.4%)
$4.61B(-0.2%)
Sep 2008
-
$1.06B(-2.3%)
$4.62B(-4.1%)
Jun 2008
-
$1.08B(-11.9%)
$4.81B(-0.6%)
Mar 2008
-
$1.23B(-1.0%)
$4.84B(+0.2%)
Dec 2007
$4.83B
$1.24B(-0.9%)
$4.83B(+7.3%)
DateAnnualQuarterlyTTM
Sep 2007
-
$1.25B(+12.9%)
$4.50B(+8.4%)
Jun 2007
-
$1.11B(-8.9%)
$4.16B(+1.9%)
Mar 2007
-
$1.22B(+33.0%)
$4.08B(+1.8%)
Dec 2006
$4.01B(-4.1%)
$917.00M(+1.1%)
$4.01B(-2.3%)
Sep 2006
-
$907.00M(-12.4%)
$4.10B(+0.0%)
Jun 2006
-
$1.03B(-9.9%)
$4.10B(-1.5%)
Mar 2006
-
$1.15B(+13.8%)
$4.16B(-0.4%)
Dec 2005
$4.18B(+10.4%)
$1.01B(+11.5%)
$4.18B(+1.4%)
Sep 2005
-
$906.00M(-17.5%)
$4.12B(+2.2%)
Jun 2005
-
$1.10B(-5.7%)
$4.04B(+2.1%)
Mar 2005
-
$1.16B(+22.0%)
$3.95B(+4.4%)
Dec 2004
$3.79B(-6.3%)
$954.00M(+16.5%)
$3.79B(+0.1%)
Sep 2004
-
$819.00M(-19.4%)
$3.78B(-3.1%)
Jun 2004
-
$1.02B(+1.9%)
$3.90B(+1.2%)
Mar 2004
-
$997.00M(+4.9%)
$3.86B(-4.5%)
Dec 2003
$4.04B(+31.2%)
$950.00M(+0.8%)
$4.04B(+18.0%)
Sep 2003
-
$942.00M(-2.7%)
$3.42B(+6.5%)
Jun 2003
-
$968.00M(-17.9%)
$3.21B(-0.6%)
Mar 2003
-
$1.18B(+254.1%)
$3.23B(+5.0%)
Dec 2002
$3.08B(-6.4%)
$333.00M(-54.6%)
$3.08B(-7.8%)
Sep 2002
-
$733.00M(-25.7%)
$3.34B(-3.8%)
Jun 2002
-
$986.00M(-3.9%)
$3.47B(+3.2%)
Mar 2002
-
$1.03B(+73.0%)
$3.36B(+1.2%)
Dec 2001
$3.29B(-81.3%)
$593.00M(-31.4%)
$3.32B(-82.1%)
Sep 2001
-
$865.00M(-1.6%)
$18.60B(+0.6%)
Jun 2001
-
$879.00M(-10.8%)
$18.49B(+4.6%)
Mar 2001
-
$985.00M(-93.8%)
$17.68B(+0.4%)
Dec 2000
$17.59B(+0.3%)
$15.87B(+1999.1%)
$17.60B(-6.2%)
Sep 2000
-
$756.00M(+950.0%)
$18.77B(+0.6%)
Jun 2000
-
$72.00M(-92.1%)
$18.66B(-3.1%)
Mar 2000
-
$906.00M(-94.7%)
$19.27B(+0.3%)
Dec 1999
$17.53B(-6.2%)
$17.04B(+2533.2%)
$19.20B(+3.5%)
Sep 1999
-
$647.00M(-4.3%)
$18.56B(-0.1%)
Jun 1999
-
$676.00M(-19.8%)
$18.58B(-0.5%)
Mar 1999
-
$843.00M(-94.9%)
$18.66B(-0.1%)
Dec 1998
$18.68B(+555.2%)
$16.39B(+2361.4%)
$18.68B(+414.2%)
Sep 1998
-
$666.00M(-12.7%)
$3.63B(-0.2%)
Jun 1998
-
$763.00M(-11.2%)
$3.64B(-9.3%)
Mar 1998
-
$859.00M(-36.1%)
$4.01B(-6.8%)
Dec 1997
$2.85B(-29.4%)
$1.34B(+100.1%)
$4.31B(+8.3%)
Sep 1997
-
$672.00M(-40.8%)
$3.98B(-6.3%)
Jun 1997
-
$1.14B(-1.6%)
$4.25B(+3.2%)
Mar 1997
-
$1.15B(+13.6%)
$4.12B(+1.8%)
Dec 1996
$4.04B(+11.6%)
$1.02B(+8.1%)
$4.04B(+1.5%)
Sep 1996
-
$940.00M(-6.5%)
$3.98B(+3.1%)
Jun 1996
-
$1.00B(-6.9%)
$3.86B(+3.0%)
Mar 1996
-
$1.08B(+13.1%)
$3.75B(+9.9%)
Dec 1995
$3.62B(+71.0%)
$955.00M(+16.5%)
$3.41B(-11.4%)
Sep 1995
-
$820.00M(-8.0%)
$3.85B(+9.3%)
Jun 1995
-
$891.00M(+20.1%)
$3.52B(+11.7%)
Mar 1995
-
$742.00M(-46.8%)
$3.15B(+5.1%)
Dec 1994
$2.12B(+6.8%)
$1.39B(+183.3%)
$3.00B(+2.3%)
Sep 1994
-
$492.00M(-5.7%)
$2.93B(+11.3%)
Jun 1994
-
$522.00M(-11.4%)
$2.63B(+23.0%)
Mar 1994
-
$589.00M(-55.6%)
$2.14B(+35.1%)
Dec 1993
$1.98B(+2407.0%)
$1.33B(+580.0%)
$1.58B(+439.5%)
Sep 1993
-
$195.00M(+541.4%)
$293.60M(+165.2%)
Jun 1993
-
$30.40M(-6.5%)
$110.70M(+14.0%)
Mar 1993
-
$32.50M(-9.0%)
$97.10M(+22.4%)
Dec 1992
$79.10M(+87.0%)
$35.70M(+195.0%)
$79.30M(+45.2%)
Sep 1992
-
$12.10M(-28.0%)
$54.60M(+2.2%)
Jun 1992
-
$16.80M(+14.3%)
$53.40M(+14.1%)
Mar 1992
-
$14.70M(+33.6%)
$46.80M(+10.4%)
Dec 1991
$42.30M(+45.4%)
$11.00M(+0.9%)
$42.40M(+10.7%)
Sep 1991
-
$10.90M(+6.9%)
$38.30M(+12.6%)
Jun 1991
-
$10.20M(-1.0%)
$34.00M(+7.6%)
Mar 1991
-
$10.30M(+49.3%)
$31.60M(-54.2%)
Dec 1990
$29.10M
$6.90M(+4.5%)
$69.00M(+11.1%)
Sep 1990
-
$6.60M(-15.4%)
$62.10M(+11.9%)
Jun 1990
-
$7.80M(-83.6%)
$55.50M(+16.4%)
Mar 1990
-
$47.70M
$47.70M

FAQ

  • What is HCA Healthcare annual EBITDA?
  • What is the all time high annual EBITDA for HCA Healthcare?
  • What is HCA Healthcare annual EBITDA year-on-year change?
  • What is HCA Healthcare quarterly EBITDA?
  • What is the all time high quarterly EBITDA for HCA Healthcare?
  • What is HCA Healthcare quarterly EBITDA year-on-year change?
  • What is HCA Healthcare TTM EBITDA?
  • What is the all time high TTM EBITDA for HCA Healthcare?
  • What is HCA Healthcare TTM EBITDA year-on-year change?

What is HCA Healthcare annual EBITDA?

The current annual EBITDA of HCA is $13.90B

What is the all time high annual EBITDA for HCA Healthcare?

HCA Healthcare all-time high annual EBITDA is $18.68B

What is HCA Healthcare annual EBITDA year-on-year change?

Over the past year, HCA annual EBITDA has changed by +$1.18B (+9.24%)

What is HCA Healthcare quarterly EBITDA?

The current quarterly EBITDA of HCA is $3.73B

What is the all time high quarterly EBITDA for HCA Healthcare?

HCA Healthcare all-time high quarterly EBITDA is $17.04B

What is HCA Healthcare quarterly EBITDA year-on-year change?

Over the past year, HCA quarterly EBITDA has changed by +$180.00M (+5.06%)

What is HCA Healthcare TTM EBITDA?

The current TTM EBITDA of HCA is $14.08B

What is the all time high TTM EBITDA for HCA Healthcare?

HCA Healthcare all-time high TTM EBITDA is $19.27B

What is HCA Healthcare TTM EBITDA year-on-year change?

Over the past year, HCA TTM EBITDA has changed by +$958.00M (+7.30%)
On this page